Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 8.35%862.68 | 796.20 | 722.52 | 814.32 | 784.51 |
| Cost Of Revenue | 14.49%528.57 | 461.69 | 402.41 | 517.13 | 510.54 |
| Gross Profit | 0.12%334.12 | 334.51 | 320.11 | 297.19 | 273.97 |
6.10%139.65 | 148.72 | 138.86 | - | - | |
| Selling, General, and Administrative | 6.10%139.65 | 148.72 | 138.86 | - | - |
| Research and Development | 75.24%68.37 | 39.02 | 38.38 | - | - |
| Operating Income/Loss | 26.47%95.42 | 129.77 | 141.77 | 112.03 | 70.34 |
| Nonoperating Income/Loss | 36.71%-80.36 | -58.78 | -61.60 | -56.80 | -75.57 |
| Income/Loss From Continuing Operations Before Tax | 78.79%15.06 | 70.99 | 80.18 | 55.24 | -5.22 |
| Income Tax Expense/Benefit | 99.93%2.75 | 1.38 | 2.18 | 5.66 | -23.36 |
82.32%12.31 | 69.61 | 78.00 | 49.57 | 18.13 | |
| Attributable To Parent | 137.62%-21.70 | 57.66 | 62.26 | 35.08 | 2.37 |
| Available To Common Stockholders, Basic | 137.62%-21.70 | 57.66 | 62.26 | 35.08 | 2.37 |
| Attributable To Noncontrolling Interest | 65.34%19.76 | 11.95 | 15.74 | 14.50 | 15.76 |
| Basic Average Shares | 5.18%335.73 | 319.20 | 316.02 | 0.37 | 314.17 |
| Diluted Average Shares | 2.33%335.73 | 328.10 | 328.93 | 1.10 | 324.75 |
| Basic Earnings Per Share | 133.33%-0.06 | 0.18 | 0.20 | 0.11 | 0.01 |
| Diluted Earnings Per Share | 133.33%-0.06 | 0.18 | 0.19 | 0.11 | 0.01 |